Key result
CAVI results in valve leaflet non-coaptation in severe TR with a prominent Eustachian ridge.
Why the study?
Severe symptomatic tricuspid regurgitation remains undertreated and challenges with transcatheter caval valve implantation need to be understood.
Case Report (n=1)
A prominent Eustachian ridge may lead to non-coaptation of valve leaflets during transcatheter caval valve implantation for severe tricuspid regurgitation, highlighting a specific anatomical challenge for this therapy.
Answers are grounded in this paper and cite their sources.
May limit caval valve success in variant anatomy; leaves open refined pre-procedural imaging criteria.
Severe symptomatic tricuspid regurgitation (TR) remains an undertreated disease. Multiple trans-catheter treatment options are currently under investigation. Transcatheter caval valve implantation (CAVI) has been utilized as a treatment option and aims at decreasing or eliminating the caval backflow that occurs in severe TR patients. Understanding challenges with this therapy is paramount. Hereby we present a CAVI case with resultant non-coaptation of valve leaflets in a patient with a prominent Eustachian ridge.
No takes yet. Share an insight, caveat, or question.
Qintar et al. (2021) conducted a case report in Severe symptomatic tricuspid regurgitation (n=1). Transcatheter caval valve implantation (CAVI) was evaluated on Valve leaflet coaptation. Transcatheter caval valve implantation in a patient with severe tricuspid regurgitation and a prominent Eustachian ridge resulted in non-coaptation of the valve leaflets.
Synapse has enriched 10 related papers. Consider them for comparative context: